INIS
patients
100%
rats
53%
drugs
43%
hospitals
34%
therapy
33%
safety
32%
plasma
30%
levels
29%
concentration
28%
doses
24%
peptides
21%
diabetes mellitus
19%
angiotensin
18%
receptors
18%
clinical trials
17%
antibiotics
17%
indonesia
17%
hiv
16%
administration
16%
comparative evaluations
16%
surveys
16%
inflammation
16%
populations
15%
blood
14%
cost
14%
interactions
13%
interventions
12%
control
12%
glucose
11%
internal medicine
11%
fluids
11%
sodium
11%
kidneys
11%
proteins
11%
doxorubicin
10%
partition
10%
hepatitis
10%
pediatrics
10%
risks
8%
liver
8%
males
8%
hypertension
7%
heart failure
7%
data
7%
reduction
7%
antioxidants
6%
diseases
6%
mutations
6%
insulin
6%
regulations
6%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
21%
Indonesia
18%
Rifampicin
18%
Plasma Concentration
16%
Clinical Trials
16%
Atrial Natriuretic Peptide
16%
Jakarta
14%
Sprague-Dawley Rats
13%
Cardioprotection
11%
Healthy Volunteers
10%
Extracellular Volume
10%
Mangiferin
10%
Internal Medicine Wards
10%
Pre-diabetes (pre-DM)
10%
Primaquine
10%
Ritonavir
10%
L-NAME
10%
Double-blind Randomized Controlled Trial
10%
Doxorubicin
10%
Angiotensin II (Ang II)
10%
Andrographis Paniculata
10%
Oxidative Stress
10%
Losartan
9%
Adverse Drug Reaction
9%
Pioglitazone
9%
Efavirenz
9%
Placebo
9%
Asian Population
8%
Hematocrit
8%
Safety Profile
8%
Drug Administration
8%
Nevirapine
8%
Enalapril
7%
Renin-angiotensin System
7%
Hypertension
7%
Co-infected Patients
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
6%
Asian Patients
6%
Angiotensin
6%
Ejection Fraction
6%
Antioxidant Effect
6%
Prospective Cohort Study
6%
Nicardipine
6%
Elderly Patients
6%
Dipeptidyl peptidase-4 (DPP-4)
6%
Retrospective Cohort Study
6%
MRNA Expression
6%
Single-dose Studies
6%
Adrenoceptors
5%
Postprandial Glucose
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rifampicin
18%
Clinical Trial
17%
Non Insulin Dependent Diabetes Mellitus
16%
Adverse Event
13%
Sprague Dawley Rat
13%
Randomized Controlled Trial
13%
Placebo
12%
Observational Study
12%
Adverse Drug Reaction
12%
Primaquine
10%
Ritonavir
10%
Doxorubicin
10%
Mangiferin
10%
Angiotensin
10%
Normal Human
10%
Atrial Natriuretic Factor
10%
Andrographis paniculata
10%
Myocardial Disease
9%
Pioglitazone
9%
HIV
9%
Efavirenz
9%
Antioxidant
9%
Drug Administration
9%
Cardiovascular Disease
8%
Inflammation
8%
Nevirapine
8%
Arginine Methyl Ester
8%
Angiotensin II
8%
Renin
8%
Drug Interaction
7%
Diabetes Mellitus
7%
Messenger RNA
7%
Congestive Heart Failure
7%
Combination Therapy
7%
Nicardipine
7%
Losartan
7%
Incretin
6%
Nitric Oxide
6%
Adrenergic Receptor
6%
Retrospective Study
6%
Creatinine
6%
Glucagon-Like Peptide-1
6%
Cohort Study
6%
Pharmacokinetics
6%
Breast Cancer
5%
Myostatin
5%
Amiodarone
5%
Advanced Glycation End Product
5%
Endoxifen
5%
QT Prolongation
5%